American Society of Hematology

ASH is the leader in representing the interests of scientists and clinicians working in the field of hematology on Capitol Hill and within federal agencies concerned with the study and treatment of blood-related diseases.

SCD Initiative 

Sickle Cell Disease Initiative

A multi-faceted initiative to identify the highest priority actions needed to improve the outcomes for individuals with SCD in the U.S. and globally.

Fight for Hematology 

Advocacy Leadership Institute

Provides opportunities to learn more about advocacy, health policy, and the legislative process, and to become engaged in the Society’s activities.

CAC Networking Meeting

Learn about the yearly ASH-ASCO Carrier Advisory Committee (CAC) Network Meeting.

Congressional Fellowship

Provides education about the policy making process, including Congress’ relationship to the hematology community.

MACRA Resources

Get an overview of the Medicare Access and CHIP Reauthorization Act (MACRA) and its impact on hematology.

Drug Access Issues

Keep informed of newly approved therapies, safety and prescription matters, and shortages of critical hematologic drugs.

  • Join Your Hematology Colleagues to Take Action in Support of NIH Funding

    The Society is committed to protecting public health and research funding and is recommending at least $44.7 billion for the NIH in FY 2021, a $3 billion (7.2 percent) increase over the NIH’s current program funding level. This funding level would allow for meaningful growth above inflation in the base budget and would expand NIH’s capacity to support promising science in all disciplines across the agency.


  • Urge Your Member of Congress to Support CMS' Changes to E/M Payments

    In the recent Physician Fee Schedule (PFS) final rule, the Centers for Medicare & Medicaid Services (CMS) finalized the first significant changes to the documentation requirements and payment of outpatient evaluation and management (E/M) services. These changes will better recognize the complex care American Society of Hematology (ASH) members deliver to their patients.

  • Thank Your Members of Congress for Their Commitment to NIH Funding in FY 2020

    Because of your efforts and the work of medical research advocates across the country, Congress passed final fiscal year (FY) 2020 appropriations legislation in late December that included a $2.6 billion dollar increase to the NIH for a total funding level of $41.7 billion.  

  • Write the New Jersey Governor to Support Patients' Access to Care

    Vital access to care legislation has passed both chambers of the New Jersey Legislature and has been sent to the Governor’s desk. This legislation, A.2431, would ensure patients have access to the life-saving medication prescribed to them by their physicians and will place maximums on the out-of-pocket costs that patients can be required to pay for each prescription medication, regardless of the disease.

View all action alerts
  • CAR T-cell Therapy: An Update on Coverage and Reimbursement

    ASH continues to advocate for adequate coverage and reimbursement for chimeric antigen receptor T-cell (CAR-T) therapy. In early August, the Centers for Medicare and Medicaid Services (CMS) finalized policies impacting both reimbursement of and coverage for CAR-T therapy. The final Inpatient Prospective Payment System (IPPS) rule, published on August 2, and the final Decision Memo for CAR T-cell Therapy for Cancers, issued August 7.

  • 2018 ASH Advocacy Activities

    ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2018.

  • 2018 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait

    ASH continues to invest in and explore the important actions needed to make a significant difference in sickle cell disease (SCD) access to care, research, and global issues. Learn about the major advocacy-related initiatives undertaken by ASH in 2018.

  • 2018 ASH Advocacy Efforts to Ensure Patient Access to Care

    In 2018, ASH worked to ensure patient access to care through a number of methods including ensuring drug access, pain management-related issues, and the Affordable Care Act.

View all policy news
View all testimony
back to top